Samrat Pharmachem

356.95
+7.00
(2.00%)
Market Cap
110.26 Cr
EPS
23.02
PE Ratio
15.20
Dividend Yield
0.29 %
Industry
Healthcare
52 Week High
646.00
52 Week Low
302.05
PB Ratio
1.51
Debt to Equity
0.21
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,679.50
#1 4,02,968.31
35.11
#1 52,041.20
12.06
#1 10,980
-18.99
49.60
6,900.00
1,83,173.32
83.20
9,360.00
0.89
2,117
23.05
67.24
1,512.50
1,22,165.81
23.68
28,409.50
7.12
5,291
30.28
52.75
3,372.90
1,14,154.26
58.56
11,317.00
11.59
2,054
10.91
59.08
1,297.90
1,08,318.98
19.45
33,741.20
12.36
5,725
21.14
49.51
2,447.70
1,01,023.62
49.11
12,207.40
19.57
1,925
-10.91
49.97
1,003.00
1,00,925.27
21.53
22,573.80
13.82
3,977
-0.19
69.48
1,984.80
90,644.92
27.22
22,192.10
#1 19.94
3,024
#1 112.49
47.26
34,850.00
74,053.82
53.31
6,409.15
10.80
1,417
27.83
71.69
1,192.60
69,266.40
#1 19.42
31,378.10
17.55
3,366
-0.50
55.14
Forecast
Actual
Growth Rate
Revenue Growth
-9.03 %
Net Income Growth
-86.75 %
Cash Flow Change
199.68 %
ROE
-87.36 %
ROCE
-86.90 %
EBITDA Margin (Avg.)
-82.65 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
48
62
71
93
112
138
180
222
311
283
286
Expenses
46
61
67
87
108
131
170
198
287
279
276
EBITDA
2
1
4
6
4
7
9
25
24
4
10
Operating Profit %
2 %
2 %
5 %
6 %
3 %
5 %
5 %
11 %
8 %
1 %
4 %
Depreciation
0
0
0
0
0
0
1
1
1
1
1
Interest
1
1
1
1
1
1
1
1
1
1
1
Profit Before Tax
1
0
3
5
2
6
7
24
23
3
10
Tax
0
0
1
2
1
2
2
6
6
0
3
Net Profit
0
0
2
3
2
4
5
17
17
2
7
EPS in ₹
1.02
0.97
5.68
10.41
4.97
13.71
17.26
55.62
53.83
7.00
23.02

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
26
36
36
41
40
58
57
85
117
122
122
Fixed Assets
7
7
7
7
7
7
9
10
11
11
11
Current Assets
19
28
28
33
33
50
47
71
99
103
103
Capital Work in Progress
0
0
0
0
0
1
0
0
0
0
0
Investments
0
2
0
0
0
0
0
0
2
3
38
Other Assets
19
27
29
34
33
50
48
75
104
108
0
Total Liabilities
26
36
36
41
40
58
57
85
117
122
122
Current Liabilities
12
21
19
21
19
34
27
37
53
56
50
Non Current Liabilities
1
2
2
1
1
0
0
1
0
0
0
Total Equity
14
14
15
19
20
24
30
47
63
65
72
Reserve & Surplus
10
11
12
15
17
21
27
44
60
62
69
Share Capital
3
3
3
3
3
3
3
3
3
3
3

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
-0
-1
-1
1
-1
0
15
-3
-2
Investing Activities
0
-2
1
-2
2
-2
-3
-1
-3
-0
Operating Activities
-1
-0
-3
0
2
-1
5
18
-9
9
Financing Activities
0
2
1
2
-4
2
-2
-2
10
-11

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 1 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.3 0.32 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
25 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2025 397.25 349.95
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 343.95 349.95
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 322.60 397.25
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 382.65 338.55
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 584.55 469.35
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2024 357.60 556.75
19 Sept 2024 DIVIDEND Dividend
₹ 1.00 /share
19 Sept 2024 357.60 633.60
18 Sept 2023 DIVIDEND Dividend
₹ 1.00 /share
18 Sept 2023 482.20 403.50
23 Sept 2022 DIVIDEND Dividend
₹ 1.00 /share
22 Sept 2022 444.00 1,149.10

Announcements

Announcement under Regulation 30 (LODR)-Resignation of Director2 days ago
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A7 days ago
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 30-06-202510 days ago
Closure of Trading Window10 days ago
Announcement under Regulation 30 (LODR)-Credit RatingJun 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 03, 2025
Audited Financial Results For The Year Ended March 31 2025May 30, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held TodayMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Board Meeting Intimation for Notice Of Board Meeting For Approval Of Audited Financial Results For The Financial Year Ended March 31 2025Mar 26, 2025
Closure of Trading WindowMar 20, 2025
Integrated Filing (Financial)Mar 04, 2025
General Announcement-Outcome Of Board Meeting (14-02-2025)Feb 14, 2025
Outcome Of The Board Meeting Held Today - 14-02-2024Feb 14, 2025
Approval Of Un-Audited Financial Results For The Quarter Ended December 31 2024Feb 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held TodayFeb 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Announcement under Regulation 30 (LODR)-Change in RTAJan 13, 2025
Closure of Trading WindowDec 31, 2024
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended December 31 2024Dec 31, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 21, 2024
Un-Audited Financial Results For The Quarter Ended September 30, 2024Nov 14, 2024
Board Meeting Outcome for Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024Nov 14, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 18, 2024
Closure of Trading WindowSep 27, 2024
Board Meeting Intimation for Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024Sep 27, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2024
Book ClosureSep 04, 2024
Record Date: Thursday, September 19, 2024Sep 04, 2024
Reg. 34 (1) Annual Report.Sep 04, 2024
32Nd Annual General Meeting On Thursday, September 26, 2024Sep 04, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 23, 2024
Un-Audited Financial Results For The Quarter Ended June 30, 2024Aug 13, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held TodayAug 13, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementAug 07, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementJul 25, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 18, 2024
Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 04, 2024
Closure of Trading WindowJun 29, 2024
Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended June 30, 2024Jun 29, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 03, 2024
Audited Financial Results For The Year Ended March 31, 2024May 30, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held TodayMay 30, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMApr 29, 2024
Compliance Certificate Under Regulation 40(9), (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, For The Year Ended March 31, 2024Apr 18, 2024
Compliance Certificate Under Regulation 7(3) For The Period: 01St April 2023 To 31St March, 2024Apr 10, 2024

Technical Indicators

RSI(14)
Neutral
48.14
ATR(14)
Less Volatile
16.58
STOCH(9,6)
Neutral
50.67
STOCH RSI(14)
Neutral
67.98
MACD(12,26)
Bullish
1.81
ADX(14)
Weak Trend
16.20
UO(9)
Bearish
34.16
ROC(12)
Uptrend And Accelerating
2.29
WillR(14)
Neutral
-60.48